Escalating Bundibugyo Ebola Outbreak in the Democratic Republic of Congo

Since May, the Democratic Republic of Congo (DRC) has reported more than 7,000 infections with the Bundibugyo strain of Ebola, resulting in a case-fatality rate of roughly 50 % according to World Health Organization-compiled government data. The outbreak is described by health officials as the fastest-growing Ebola episode in recent memory and the most severe since the 2014-16 West Africa crisis. While neighboring Uganda succeeded in halting transmission through intensive contact tracing, isolation, and clinical care, persistent armed conflict and mass displacement in the DRC have impeded similar efforts.

Wired Magazine

Nicole Lurie, executive director for preparedness and response at the Coalition for Epidemic Preparedness Innovations (CEPI) and U.S. CEPI redirected $100 million of internal funding toward vaccine development shortly after the first cases emerged. This financing enabled the Serum Institute of India to produce doses of Oxford University’s ChAdOx1 BDBV vaccine at record speed and supported Moderna’s parallel candidate. Both vaccines have entered safety trials, with efficacy studies slated to begin later this month, contingent on effective contact-tracing infrastructure.

Wired Magazine

Humanitarian workers face violent resistance: Red Cross volunteers have been attacked, medical equipment destroyed, and safe-burial teams delayed. Such hostility undermines contact tracing, a cornerstone of outbreak control. Additionally, local skepticism toward external health interventions threatens vaccine uptake.

Wired Magazine

• “Other than Covid, which affected the whole world, this is the thing that has frightened me the most,” — Nicole Lurie

Wired Magazine

• “I don’t think we’re going to be able to bring this to an end without a vaccine,” — Nicole Lurie

Wired Magazine